Detalles de la búsqueda
1.
Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes.
Diabet Med
; 36(6): 771-775, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30466191
2.
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.
Diabet Med
; 34(2): 189-196, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27589252
3.
One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial.
Diabetes Obes Metab
; 17(10): 965-73, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25980900
4.
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin.
Diabetes Obes Metab
; 16(12): 1257-64, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25155146
5.
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial.
Diabet Med
; 30(11): 1293-7, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23710902
6.
Continuous glucose monitoring in 2010.
Int J Clin Pract Suppl
; (170): 10-5, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21323807
7.
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes.
Diabetes Obes Metab
; 12(7): 604-12, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20590735
8.
Continuous glucose monitoring.
Int J Clin Pract Suppl
; (166): 11-5, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20377658
9.
Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.
Diabetes Care
; 24(1): 69-72, 2001 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11194244
10.
Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.
Diabetes Care
; 19(4): 324-7, 1996 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-8729154
11.
Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use.
Diabetes Technol Ther
; 2(1): 49-56, 2000.
Artículo
en Inglés
| MEDLINE | ID: mdl-11467320
12.
Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study.
Diabetes Res Clin Pract
; 46(3): 183-90, 1999 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-10624783
13.
What's ahead in glucose monitoring? New techniques hold promise for improved ease and accuracy.
Postgrad Med
; 109(4): 41-4, 47-9, 2001 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11317468
14.
Clinical utility of the continuous glucose monitoring system.
Diabetes Technol Ther
; 2 Suppl 1: S35-41, 2000.
Artículo
en Inglés
| MEDLINE | ID: mdl-11469630
15.
Using the continuous glucose monitoring system to improve the management of type 1 diabetes.
Diabetes Technol Ther
; 2 Suppl 1: S43-8, 2000.
Artículo
en Inglés
| MEDLINE | ID: mdl-11469631
Resultados
1 -
15
de 15
1
Próxima >
>>